BTIG has initiated a 'Buy' rating for ONE Gas, citing large load growth opportunities as the primary driver for their positive outlook.

BTIG analysts suggest that tech stocks are still struggling, advising investors to watch for further declines after the Nasdaq Composite experienced its worst day since April 2025.

BTIG has reduced its price target for Duke Energy (DUK) by $2, while still maintaining a 'Buy' rating for the stock.

BTIG has increased its price target for Core Scientific, attributing the adjustment to the company's recent expansion in power capacity, which is expected to enhance its operational capabilities.

BTIG initiated research coverage on a biotech company with a buy rating, suggesting its experimental hair loss treatment could be a 'GLP-1 moment' for the condition, akin to the impact of GLP-1 drugs on weight loss.

Cloud data management company Rubrik is under investor focus after BTIG reiterated its Buy rating following positive checks.

BTIG strategist Julian Krinsky has outlined seven warning signs and two positive indicators for the current market environment, offering insights into potential future trends.

BTIG has increased its price target for cybersecurity firm CrowdStrike to $621, citing a strengthening narrative around platform consolidation in the industry. This upgrade reflects confidence in CrowdStrike's market position.

Analysts suggest that Fortinet, along with Cloudflare, is likely to be a beneficiary of advancements in post-quantum cryptography. Additionally, Fortinet is identified as a stock that could play a significant role in the AI 'endgame.'

BTIG has named Firefly Aerospace as a winner in the Moon landing sector, highlighting its achievements in lunar missions.

BTIG and Jefferies maintain a bullish outlook on MercadoLibre (MELI), even as the company faces margin pressures.

BTIG has reduced its price target for Atlassian to $110, raising questions about the momentum of the company's cloud transition strategy.

BTIG has reiterated its Buy rating for CoStar Group (CSGP) stock.

Mizuho, BTIG, and Evercore have all lowered their price targets for Intuitive Surgical (ISRG), indicating a revised outlook for the medical device company.

BTIG has revised its financial model for Merit Medical Systems, Inc. (MMSI) in anticipation of upcoming changes to Medicare payment policies.

BTIG has reiterated its "Buy" rating for T1 Energy (TE), even after the company experienced a particularly difficult financial quarter.

BTIG, a global financial services firm, has initiated coverage on several prominent food companies. These include General Mills, J. M. Smucker, Conagra, and Campbell's, with some receiving a "Buy" rating.

BTIG has begun its coverage of software companies Adobe and Figma, assigning both a 'Neutral' rating.

BTIG has cut its rating on Zscaler to Neutral, raising questions about whether the cybersecurity boom has already been fully priced into the stock's current valuation.

Investment firms Evercore ISI and BTIG have both lowered their price targets for Abbott (ABT) but continue to maintain positive ratings on the stock. This indicates a cautious but still optimistic view on the company's future performance.

BTIG’s Jonathan Krinsky suggests the S&P 500 index requires a significant selloff to 6,000 before it can achieve a fresh record high.

BTIG has lowered its price target for Humacyte (HUMA) but continues to hold a bullish view on the company's long-term opportunities.

BTIG has reduced its price target for Nexxen International Ltd. (NEXN) but continues to assert a 'Buy' stance on the stock.

Upstart's stock saw a rise after a BTIG analyst projected a 55% upside, citing the fintech company's plan to secure a banking charter as a key catalyst that could reduce its exposure to private credit risks.

The financial firm upgraded the artificial intelligence lending marketplace to buy from neutral.

BTIG has downgraded OneStream (OS) after the company entered into a $24-per-share buyout agreement, prompting an analyst re-evaluation.

BTIG has issued a neutral rating for Crocs, citing a delayed inflection point for the company's North American sales.

BTIG highlights a potential warning sign in the market as WTI crude oil prices soar, but energy stocks are not showing a corresponding upward trend, suggesting a lack of confirmation.

BTIG has labeled Domino's as undervalued, citing the pizza company's impressive gains in market share.

Analysts express skepticism towards nCino and caution on Guidewire Software, citing broader headwinds affecting the software sector.

BTIG maintains a positive outlook on Palo Alto Networks as recent channel checks indicate improving conditions for the company.

BTIG analysts maintain a bullish outlook on Boston Scientific (BSX) stock, providing insights into their assessment of the company's performance and market position.

U.S. Bancorp (USB) has successfully finalized its acquisition of BTIG, LLC, a global financial services firm specializing in institutional trading and brokerage.

BTIG analysts suggest that Medtronic's shares are currently trading at a discount compared to its competitors, making it an opportune time for investment.

Barclays and BTIG have both increased their price targets for Bloom Energy, following a strong quarter and a new partnership with Oracle.

BTIG warns that South Korea's Kospi index is vulnerable to a significant drop because of its heavy reliance on major companies like Samsung and SK Hynix.

BTIG has withdrawn its Buy rating for Organogenesis Holdings Inc. (ORGO) following the company's first-quarter update, raising questions about the stock's momentum.

BTIG has reduced its price target for MercadoLibre, Inc. (MELI) following a reset in the company's margins to approximately 7%. This adjustment reflects changes in financial expectations for the e-commerce giant.

Cybersecurity firm CrowdStrike is reportedly gaining positive momentum, according to analysis by BTIG. The specific reasons for this positive outlook are not detailed in the snippet.

BTIG has begun coverage of Hyperfine, Inc. with a bullish outlook, indicating positive prospects for the company.

Several financial institutions, including Goldman Sachs and Barclays, have increased their price targets for a diverse group of companies such as ServiceNow, Boeing, NXP Semiconductors, and Ally Financial. These adjustments reflect positive outlooks on various sectors, including AI innovation and upcoming earnings.

BTIG has reiterated its bullish stance on DexCom, Inc. (DXCM), maintaining a positive outlook for the medical device company.

BTIG has increased its price target for Twilio to $175, positioning the company as a potential key player in AI communications infrastructure.

BrightSpire's stock rating has been raised to "Buy" by BTIG, citing strong earnings and a positive portfolio growth outlook.

Barclays cut its price target for Smucker (SJM) to $103 due to cost concerns, while BTIG initiated coverage with a "Buy" rating and a $120 target, reflecting differing analyst perspectives on the company's outlook.

Flywire has received an upgrade to "Buy" from BTIG, citing an attractive risk/reward profile for the company's stock.

BTIG's chief market technician, Jonathan Krinsky, advises that now is an opportune time for investors to buy bonds.

According to BTIG, software stocks, which have had a challenging start to 2026, may have reached a bottom, suggesting potential relief for investors in the sector.

WhiteFiber's stock experienced a significant jump following BTIG's initiation of coverage with a 'Buy' rating, indicating analyst confidence in the company.

Zscaler's stock has fallen significantly, leading declines among most cybersecurity stocks year-to-date, prompting BTIG to downgrade its rating to Neutral.

BTIG has reduced its price target for ServiceNow to $185, as the company's fiscal year 2026 revenue growth guidance draws scrutiny from analysts.

StandardAero has been rated 'Buy' by BTIG, with analysts citing aging aircraft fleets as a driver for a long-term maintenance boom in the aerospace industry.

BTIG has reiterated its "Hold" rating for VinFast Auto (VFS) stock.

BTIG has reiterated its 'Buy' rating for Howmet Aerospace Inc. (HWM) and maintained a price target of $275.

BTIG has reaffirmed its 'Buy' rating on UWM Holdings (UWMC), indicating continued confidence in the company's stock performance.

BTIG has revised its price target for AeroVironment, Inc. (AVAV) to $330 while reiterating a 'Buy' rating for the company's stock.

BTIG has increased its price target for Opus Genetics, Inc. (IRD) from $7 to $12, while maintaining a 'Buy' rating on the stock.

BTIG has raised its target for Costco (COST), citing strong membership income and consistent traffic at its stores.

BTIG analysts have issued a warning that a break below the 6,700 level could send the S&P 500 index towards its 200-day moving average, indicating potential market volatility.

Jonathan Krinsky of BTIG suggests that investors should transition to an offensive positioning strategy, implying a more aggressive approach to market investments.

BTIG has expressed a positive outlook on Ralph Lauren (RL), attributing its stance to the company's margin expansion.

BTIG has reiterated its 'Buy' rating for Praxis Precision Medicines (PRAX), indicating continued confidence in the company's stock performance and prospects.

BTIG has increased its price target for Rapport Therapeutics (RAPP), signaling a positive outlook for the company's stock.

Medtronic received an upgrade from BTIG after reporting better-than-expected financial results for its fiscal year 2026 fourth quarter. The upgrade reflects positive analyst sentiment regarding the company's performance.

According to BTIG, BETA Technologies (BETA) holds a dominant position in the eVTOL Integration Pilot Program Initiative, highlighting its leadership in the electric vertical takeoff and landing sector.

Cerus Corporation (CERS) has received an upgrade to 'Buy' from BTIG following the release of its first-quarter results. This upgrade signals a positive re-evaluation of the company's stock.

BTIG, an investment banking firm, has cast doubt on recent reports regarding a potential buyout of Papa John's, suggesting the claims lack substance.

BTIG has reiterated its 'Buy' rating for US Foods Holding (USFD).

A biopharmaceutical company focused on anti-aging treatments has experienced a significant surge in its stock price this year. Investment firm BTIG has initiated coverage with a buy rating, predicting further growth.

BTIG has adopted a bullish stance on Palo Alto Networks, increasing its price target for the company's stock to $216. This positive outlook is based on improving channel checks.

BTIG analysts have issued a 'Buy' rating for Mondelez International, citing the company's stable valuation as a key factor in their assessment.

BTIG, an investment bank, has raised its price target for NextEra Energy (NEE) to $112. This adjustment reflects a positive outlook on the energy company's future performance.

Unity's Vector platform continues its expansion as the company prepares to sunset ironSource, according to an analysis by BTIG.

Investment firms Jefferies and BTIG have reiterated their bullish outlooks on MercadoLibre (MELI) stock.

Climb Bio (CLYM) has been granted FDA Fast Track designation, and BTIG has issued a "Buy" rating for the small-cap stock. This news has sparked discussions about the company's investment potential.

Dick's Sporting Goods has been given a bull rating by BTIG, with analysts expecting the company's deal involving Foot Locker to yield positive returns.

BTIG, an investment bank, has reiterated its Buy rating on Insulet (PODD). This indicates a positive outlook from the firm on the company's stock performance.

BTIG has launched its coverage of the food sector, identifying Mondelez, Smucker, and Utz as favored stocks for investors.

Utility stocks Ameren and Evergy have been started with "Buy" ratings by BTIG, indicating a positive outlook from the investment firm.

ImmunityBio (IBRX) has been issued a warning by the FDA, though investment firm BTIG has indicated it will maintain a positive stance on the company's prospects.

BTIG has upgraded its rating for Upstart Holdings, Inc. (UPST), noting that a potential bank charter could significantly reduce the company's funding risk.

BTIG analysts predict that FTAI Aviation stock could surge by 43% from its current levels, setting a target price of $340.

BTIG analysts are projecting an upside for ImmunityBio, Inc. (IBRX), attributing their positive outlook to strong anticipated sales growth for ANKTIVA in 2026.

Upstart's stock has been upgraded to a 'Buy' rating by BTIG after the company submitted an application for a national bank charter, signaling potential growth.

StoneX is set to pay approximately $1.8 million to BTIG to resolve a 2023 complaint related to the hiring of former BTIG employees, concluding a corporate dispute.

Alector's stock has seen a rise after BTIG upgraded the company's rating to Buy, citing a strategic shift.

Valaris has received a downgrade from BTIG analysts after a significant run-up in its stock price, which followed news of a potential merger with Transocean.

BTIG has maintained its Neutral rating on Affirm Holdings (AFRM), citing data from the January 2026 Trust.

BTIG has lowered its price target for Domino’s (DPZ), citing concerns over the company's same-store sales growth.